Does ischemia-free machine perfusion lead to early allograft dysfunction (EAD) free liver transplantation?
- PMID: 39175733
- PMCID: PMC11336541
- DOI: 10.21037/hbsn-24-250
Does ischemia-free machine perfusion lead to early allograft dysfunction (EAD) free liver transplantation?
Keywords: Early allograft dysfunction (EAD); liver transplant outcomes; normothermic machine perfusion (NMP).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-250/coif). The authors have no conflicts of interest to declare.
Comment on
-
A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease.J Hepatol. 2023 Aug;79(2):394-402. doi: 10.1016/j.jhep.2023.04.010. Epub 2023 Apr 20. J Hepatol. 2023. PMID: 37086919 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources